Peter A. Friedli

Founder at NEW VENTURETEC AG

72 year

Finance

Health Technology

Commercial Services

Profile

Peter A. Friedli is the founder of Osiris Therapeutics, Inc. (founded in 1992) where he served as Chairman from 1992 to 2019.
He is also the founder of Invenda Corp.
(founded in 1996) where he currently holds the position of Director.
Additionally, he is the founder of New Venturetec AG (founded in 1997) where he currently holds the position of Chairman and Chairman of the Board of Directors.
Mr. Friedli's current job(s) include being a Director at Vertical Circuits, Inc. and a Director at Prolexys Pharmaceuticals, Inc.Mr. Friedli's former job(s) include being the Chief Executive Officer at Pine Investments AG (from 1986 to 2012), Chairman at Inflabloc Pharmaceuticals, Inc., Chairman at ReVerb Networks, Inc., Director at mPortal, Inc., and President at Venturetec, Inc.

Peter A. Friedli active positions

Companies	Position	Start
NEW VENTURETEC AG	Founder	1997-07-15
Invenda Corp. Invenda Corp. Advertising/Marketing ServicesCommercial Services Provides interactive marketing technologies and services via the Internet	Founder	1995-12-31
Prolexys Pharmaceuticals, Inc. Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	-
Vertical Circuits, Inc. Vertical Circuits, Inc. SemiconductorsElectronic Technology Manufactures semiconductors and electronic capacitors	Director/Board Member	-
New Venturetec AG /Venture Capital/ New Venturetec AG /Venture Capital/ Investment ManagersFinance New Venturetec invests in private, public companies and in all classes of securities, including common and preferred equity, secured and unsecured debt, convertibles, options, warrants and combinations thereof. The firm focuses on companies operating in the fields of biotechnology and technology. It provides financing for all stages from seed to late stage.	Founder	1997-08-07

All active positions of Peter A. Friedli

Former positions of Peter A. Friedli

Companies	Position	End
OSIRIS THERAPEUTICS, INC.	Founder	2019-04-16
Pine Investments AG Pine Investments AG Investment ManagersFinance Friedli CF aims to identify, structure, launch and manage businesses which they perceive as likely to reach the technology forefront over the next decade. The firm has invested venture capital in the biotechnology, computer technology, communications and Internet technology sectors, predominantly in the US. Friedli CF selects investments after an in-depth analysis of people, technology and potential markets, with a particularly focus on the capabilities and commitment of the management team. The firm follows a hands-on approach and influences key management and strategic decisions. They set milestones to be reached, closely monitor company development and conduct periodical management reviews.	President	2012-08-12
ReVerb Networks, Inc. ReVerb Networks, Inc. BroadcastingConsumer Services Develops and designs an integrated radio and antenna systems	Chairman	-
mPortal, Inc. mPortal, Inc. Packaged SoftwareTechnology Services Designs and develops mobile content and applications	Director/Board Member	-
░░░░░░░░░░░ ░░░░	░░░░░░░░░	-

See the detail of Peter A. Friedli's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter A. Friedli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Osiris Therapeutics, Inc. Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues	Health Technology
Invenda Corp. Invenda Corp. Advertising/Marketing ServicesCommercial Services Provides interactive marketing technologies and services via the Internet	Commercial Services
Venturetec, Inc.
New Venturetec AG New Venturetec AG Investment ManagersFinance Acts as Venture Capital Fund	Finance
Inflabloc Pharmaceuticals, Inc. Inflabloc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of pharmaceutical treatments	Commercial Services
Vertical Circuits, Inc. Vertical Circuits, Inc. SemiconductorsElectronic Technology Manufactures semiconductors and electronic capacitors	Electronic Technology
Prolexys Pharmaceuticals, Inc. Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
mPortal, Inc. mPortal, Inc. Packaged SoftwareTechnology Services Designs and develops mobile content and applications	Technology Services
Pine Investments AG Pine Investments AG Investment ManagersFinance Friedli CF aims to identify, structure, launch and manage businesses which they perceive as likely to reach the technology forefront over the next decade. The firm has invested venture capital in the biotechnology, computer technology, communications and Internet technology sectors, predominantly in the US. Friedli CF selects investments after an in-depth analysis of people, technology and potential markets, with a particularly focus on the capabilities and commitment of the management team. The firm follows a hands-on approach and influences key management and strategic decisions. They set milestones to be reached, closely monitor company development and conduct periodical management reviews.	Finance
ReVerb Networks, Inc. ReVerb Networks, Inc. BroadcastingConsumer Services Develops and designs an integrated radio and antenna systems	Consumer Services
New Venturetec AG /Venture Capital/ New Venturetec AG /Venture Capital/ Investment ManagersFinance New Venturetec invests in private, public companies and in all classes of securities, including common and preferred equity, secured and unsecured debt, convertibles, options, warrants and combinations thereof. The firm focuses on companies operating in the fields of biotechnology and technology. It provides financing for all stages from seed to late stage.	Finance